N-Desmethyl Vinblastine(CAS: 18172-50-4)

N-Desmethyl Vinblastine (CAS: 18172-50-4) falls under the GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for carcinogenicity and has specific REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) regulations applicable in the European Union. In the United States, it is subject to FDA (Food and Drug Administration) and EPA (Environmental Protection Agency) guidelines, including those for the handling and disposal of hazardous substances.

There are several alternatives to N-Desmethyl Vinblastine (CAS: 18172-50-4) in synthesis, such as other vinca alkaloids like Vincristine and Vinorelbine. These alternatives can serve as effective substitutes depending on the specific application, such as in anticancer therapies.

The market for N-Desmethyl Vinblastine (CAS: 18172-50-4) is largely driven by its use in oncology, particularly in the treatment of hematological malignancies. Research is focusing on its combination therapies and understanding its mechanism of action to improve efficacy and reduce side effects. Market trends show steady demand, with ongoing studies exploring its role in targeted cancer treatments.

Waste containing N-Desmethyl Vinblastine (CAS: 18172-50-4) should be collected and disposed of in accordance with local and national regulations. It should be stored in a secure, labeled container and incinerated or disposed of by a licensed professional waste disposal service. Environmental protection precautions include proper containment to prevent leaks and ensure the waste is not released into the environment.